Form 4 for GILD Gilead Sciences
Accepted 2022-07-26 00:00:00 ET · period of report 2022-07-24 · accession 0001127602-22-019775 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-26 | 2022-07-24 | GILD | Mercier Johanna | Chief Commercial Off | F - Tax | $60.80 | -3,206 | 39.4K | -8% | -$194.9K |
| D | 2022-07-26 | 2022-07-24 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | +7,505 | 42.6K | +21% | — |
| D | 2022-07-26 | 2022-07-24 | GILD | Mercier Johanna | Chief Commercial Off | M - OptEx | — | -7,505 | 52.3K | -13% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-24 | F | D | 3,206 | $60.80 | 39,371 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-24 | M | A | 7,505 | — | 42,577 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2022-07-24 | M | D | 7,505 | — | 52,288 | D | — · — to — | 7,505 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F2) The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. |